Evidence map›Paper›PMID 30326651›Full record

ArticleCells2018

Samp1 Mislocalization in Emery-Dreifuss Muscular Dystrophy.

Elisabetta Mattioli, Marta Columbaro, Mohammed Hakim Jafferali, Elisa Schena, Einar Hallberg, Giovanna Lattanzi

Open access · goldAbstract read
In one paragraph

Article in Cells, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Cutting Edge: The Role of mTOR Signaling in Laminopathies.International journal of molecular sciences · 2019
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Elisabetta MattioliCNR Institute of Molecular Genetics, Unit of Bologna, 40136 Bologna, Italy. emattiol@area.bo.cnr.it.
Marta ColumbaroLaboratory of Musculoskeletal Cell Biology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy. marta.columbaro@ior.it.
Mohammed Hakim JafferaliKTH, Science for Life Laboratory, SE 171 65 Solna, Sweden. hakim.mohmd@scilifelab.se.
Elisa SchenaCNR Institute of Molecular Genetics, Unit of Bologna, 40136 Bologna, Italy. elisaschena83@gmail.com.
Einar HallbergDepartment of Biochemistry and Biophysics (DBB), Stockholm University, SE-106 91 Stockholm, Sweden. einar.hallberg@dbb.su.se.
Giovanna LattanziCNR Institute of Molecular Genetics, Unit of Bologna, 40136 Bologna, Italy. giovanna.lattanzi@cnr.it.ORCID 0000-0002-7103-8722
Istituto Ortopedico Rizzoli · ITScience for Life Laboratory · SEStockholm University · SEUniversity of Bologna · IT

Funding

AIDMED, Associazione Italiana Distrofia Muscolare di Emery-Dreifuss Prot. 38/2016Istituto Ortopedico Rizzoli di Bologna Fondi 5 per 1000 2013 and 2014Ministero dell'Istruzione, dell'Università e della Ricerca 2015FBNB5Y
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Emery-Dreifuss Muscular Dystrophy type 2 (EDMD2)LINC complexmyonuclear positioningprelamin ASamp1 (NET5)

Identifiers

PMID30326651
PMCPMC6210792
OpenAlexW2896923446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.